Lowest Price Guaranteed
Pages
119
Last Updated
April 2026
View Count
20935
Incorporation of MES into production line can streamline material cost and time spent in production. I believe, MES has the potential to reduce 10%-30% of the overall production cost, depending on the type of industry
-- CEO, a small-sized company
The manufacturing execution system market, valued at USD 4.62 billion in 2025, is projected to grow to USD 5.36 billion in 2026 and USD 20.46 billion by 2035, representing a CAGR of 16.0% during the forecast period.
The market for manufacturing execution systems (MES) is projected to grow vigorously with several driving factors. However, the rising complexity in the manufacturing process of biologics and pharmaceuticals is one of the leading factors to accelerate the growth of the market.
 |
To learn more about this report, request a free sample copy
Over the years, constantly growing shortages of manpower in the healthcare sector combined with expanding data have fabricated immense opportunities for innovative tools & technologies to overcome the excess pressure on the healthcare industry in production process management. With regard to this, the manufacturing execution system is an innovative tool that supports manufacturing operations to monitor and track production processes in real time. It connects enterprise resource planning (ERP) and supervisory control and data acquisition (SCADA) systems which help manage production processes and monitor the physical processes on the plant floor.
In addition, the propelling penetration of advanced technology, particularly, industry 4.0, the rise of smart manufacturing in pharmaceutical and biologics contract manufacturing with digital transformation, and the Internet of Things (IoT) are increasingly promoting such advanced software solutions similar to MES in the healthcare industry. These emerging technologies have enabled connectivity and data exchange between machines, sensors, and systems that provide real-time monitoring, analysis, and optimization of production processes. Thereby, to leverage the growing demand for operational efficiency and integration of IoT, market players are continuously focusing on the development of smart manufacturing execution systems to enhance their product portfolio and competitive edge in the global MES market. Despite the advantages of the manufacturing execution system, the complexity of integration of MES with existing operating systems can cause challenges for the growth of the market.
 |
 |
 |
Tap or click on the images for smart insights on Manufacturing Execution System Market
The market research report presents an in-depth analysis of the various companies that are engaged in the global market of MES, across different segments, as defined in the table below:
| Key Report Attribute | Details | |
| Historical Trend | Since 2022 | |
| Forecast Period | Till 2035 | |
| Market Size 2026 | USD 5.36 Billion | |
| Market Size 2035 | USD 20.46 Billion | |
| CAGR (Till 2035) | 16.0% | |
| Type of Deployment |
|
|
| Type of End-User |
|
|
| Key Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
|
|
 |
 |
 |
Tap or click on the images for smart insights on Manufacturing Execution System Market
One of the key objectives of this market report was to estimate the current market size, opportunity, and future growth potential of the manufacturing execution system market, over the forecast period. Based on multiple parameters, likely adoption trends, and through primary validations, we have provided an informed estimate of the market evolution during the forecast period, till 2035. The market report also features the likely distribution of the current and forecasted opportunity within the MES market across various segments, such as type of deployment (cloud, corporate data center, hybrid, and on premise), type of end user (life science/biotechnology companies, medical device providers, pharmaceutical companies and others) and key geographical regions (North America, Europe and Asia Pacific, Latin America, Middle East, North Africa and rest of the world).
In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
The opinions and insights presented in the market research report were also influenced by discussions held with multiple stakeholders in manufacturing execution system market. The market report features detailed transcripts of interviews held with the following individuals:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
 |
 |
Tap or click on the images for smart insights on Manufacturing Execution System Market
Based on the type of deployment, the MES market is split into Cloud, Corporate Datacentre, Hybrid and On Premise. In terms of market revenue, the cloud segment acquires 68.5% of the manufacturing execution system market share. The hybrid escalates the market growth at 18.62% CAGR during this forecast period.
The growing demand for cloud-based MES solutions notably uplifts the market growth due to their flexibility, scalability, and accessibility enabling manufacturers to adjust their operations effortlessly. In addition, the seamless integration of real-time data from diverse locations enhances collaboration coupled with its decision-making capabilities and remote access functionalities. As a result, the cloud segment is poised to drive the manufacturing execution system market growth throughout the forecast period.
Based on the type of end user, the global manufacturing execution system market is bifurcated into Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies, and Others. As per our projection, medical device providers dominate the end-user segment with 51 % of the market share. Life science/biotechnology companies drive the market growth with a CAGR of 16.46% and are likely to boost the market demand as these companies highly rely on MES that aid in managing batch production, tracking, and tracing materials and products. It also ensures compliance with stringent regulatory requirements and maintains data integrity.
This segment highlights the distribution of the MES market across various geographies, such as North America, Europe, Asia-Pacific, Latin America, Middle East, and North Africa. As per market statistics, Europe accounts for 41% of the manufacturing execution system market share and holds the leading position in the global market for manufacturing execution systems. The early adoption of automation and strong demand for MES across various industries substantially contribute to the region’s leading position. In addition, the strong regulatory environment, the presence of European MES providers in the global marketplace, and the collaborative ecosystem contribute to flourishing market growth in Europe.
Furthermore, Asia Pacific’s fastest-growing economy fuels the manufacturing execution systems market growth at a CAGR of 16.8%. The region's growth is projected to continue to grow due to rapid industrialization, digitization, and an upsurge in the adoption of Industry 4.0 in various sectors, specifically, in the medical sector. Additionally, the expanding pharmaceutical industries including many life science/ biotechnology companies coupled with the increased penetration of advanced technologies, is poised to augment the market growth over this projection timeframe.
The “Manufacturing Execution System Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market forecast and future opportunities for the companies involved in providing MES solutions to pharmaceutical industry. Key takeaways of the market report are briefly discussed below.
Presently, more than 75 small, medium, and very large companies are serving in the healthcare MES market, offering integrated MES software to manage, monitor, and control the production process in the medical sector. A diverse range of software is being offered by these companies through different licensing models to cater to the medical device industry, life science biotechnology and pharmaceutical companies. Some of the prominent companies are Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation. By leveraging technological advancements, these companies are continually shaping the market dynamics.
The global manufacturing execution system market is estimated to be worth USD 5.36 billion in the current year. Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive market growth at a CAGR of more than 16% during the forecast period.
It has been observed that companies are increasingly adopting cloud-based manufacturing execution systems, to overcome the challenges associated with growing complexity of processes and global expansion of businesses. Specifically, cloud-based manufacturing execution systems integrate real-time information of different production floors and promote collaboration. In January 2024, Canada based IT Consulting company CGI Group announced collaboration with Korber for leveraging its Werum PAS-X MES Suite to serve its pharmaceutical clients. This MES suite is specifically developed for pharmaceutical and biotechnology industry and is available as either on-premise or cloud-based solution.
In recent years, with the mounting penetration of technological advancements, the market for manufacturing execution systems has been evolving exponentially. The trend of integrated quality management systems is one of the latest trends in the manufacturing execution system industry. This integrated MES with quality management system is gaining traction due to its advantages in streamlining compliance with regulatory standards such as ISO 13485 and FDA regulations for instance 21 CFR Part 820 for medical devices which allows companies to report, monitor, and traceability of quality-related data throughout the product lifecycle. Along with this, cloud-based manufacturing execution systems are gaining strong demand in the healthcare sector that facilitate manufacturing control from any location, and offer remote collaboration, decision-making, and compliance management. These cloud-based MES solutions are specifically suitable for global supply chains and distributed manufacturing networks.
According to industry experts, manufacturing execution systems have the potential to reduce 10%-30% of the overall production cost depending on the type of industry. In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system into their production lines, with an aim to connect, monitor and control the complex manufacturing process. Both the contract manufacturing and in-house manufacturing facilities are adopting industry 4.0 technologies. These technologies are allowing digital manufacturing of therapeutics and vaccines.
BioNTech collaborated with Siemens for making its Marburg, Germany facility Industry 4.0 compatible. The facility was one of the main sites for production of its COVID-19 vaccine, belonging to mRNA vaccine and therapeutics market. The company adopted Siemens’ Opcenter Execution Pharma solution as the new MES to allow paperless manufacturing.
Examples of key companies engaged in the manufacturing execution system industry (which have also been profiled in this market report; the complete list of companies is available in the full report) include Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation. This market report includes an easily searchable excel database of all the companies who are providing and have adopted the manufacturing execution systems in pharmaceutical industry.
Several recent developments have taken place in the field of manufacturing execution systems. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.